Glenn Sblendorio

Insider Reports History

Entity
Individual
Location
3 Times Sqaure, 12 Th Floor, New York, NY
Signature
/s/ Christian Formica, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Sblendorio:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMICUS THERAPEUTICS, INC. Director Common Stock 95.4K $954K $10.00 Jun 6, 2024 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 42.5K Jun 6, 2024 Direct
Mineralys Therapeutics, Inc. Director Stock Option 22K May 22, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Glenn Sblendorio

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FOLD AMICUS THERAPEUTICS, INC. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
FOLD AMICUS THERAPEUTICS, INC. Mar 7, 2024 2 $42K 4 Mar 11, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 12 -$600K 4 Nov 13, 2023 Director
MLYS Mineralys Therapeutics, Inc. Sep 13, 2023 1 $0 4 Sep 14, 2023 Director
MLYS Mineralys Therapeutics, Inc. Sep 13, 2023 0 $0 3 Sep 14, 2023 Director
ISEE IVERIC bio, Inc. Jul 11, 2023 16 $0 4 Jul 13, 2023 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Jun 22, 2023 2 $146K 4 Jun 26, 2023 Chief Executive Officer, Director
FOLD AMICUS THERAPEUTICS, INC. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
FOLD AMICUS THERAPEUTICS, INC. May 18, 2023 2 $49.8K 4 May 19, 2023 Director
ISEE IVERIC bio, Inc. Jan 2, 2023 3 -$350K 4 Jan 4, 2023 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Dec 27, 2022 1 $0 4 Dec 29, 2022 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Dec 20, 2022 2 $0 4 Dec 22, 2022 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Dec 18, 2022 3 -$419K 4 Dec 20, 2022 CEO, Director
ISEE IVERIC bio, Inc. Dec 9, 2022 4 $0 4 Dec 13, 2022 CEO, Director
ISEE IVERIC bio, Inc. Nov 2, 2022 1 -$1.15M 4 Nov 4, 2022 CEO, Director
FOLD AMICUS THERAPEUTICS, INC. Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
ISEE IVERIC bio, Inc. Apr 4, 2022 1 -$938K 4 Apr 6, 2022 CEO, Director
ISEE IVERIC bio, Inc. Mar 30, 2022 9 -$630K 4 Apr 1, 2022 CEO, Director
ISEE IVERIC bio, Inc. Mar 25, 2022 3 -$265K 4 Mar 29, 2022 CEO, Director
ISEE IVERIC bio, Inc. Mar 18, 2022 3 -$48.9K 4 Mar 22, 2022 CEO, Director
FOLD AMICUS THERAPEUTICS, INC. Mar 4, 2022 2 $71.9K 4 Mar 7, 2022 Director
ISEE IVERIC bio, Inc. Dec 30, 2021 6 -$12.7K 4 Jan 3, 2022 CEO, Director
ISEE IVERIC bio, Inc. Dec 22, 2021 14 -$882K 4 Dec 27, 2021 CEO, Director
ISEE IVERIC bio, Inc. Dec 18, 2021 3 -$286K 4 Dec 21, 2021 CEO, Director
ISEE IVERIC bio, Inc. Dec 16, 2021 2 $0 4 Dec 20, 2021 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Dec 12, 2021 3 -$122K 4 Dec 14, 2021 Chief Executive Officer, Director
ISEE IVERIC bio, Inc. Dec 9, 2021 2 $0 4 Dec 13, 2021 Chief Executive Officer, Director
FOLD AMICUS THERAPEUTICS, INC. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director